Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157: Miracle Healing Peptide or Hidden Danger? Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com